OBLN stock forecast
Our latest prediction for Obalon Therapeutics, Inc.'s stock price was made on the Nov. 12, 2019 when the stock price was at 1.69$.
In the short term (2weeks), OBLN's stock price should outperform the market by 6.74%. During that period the price should oscillate between -11.03% and +19.32%.
In the medium term (3months), OBLN's stock price should outperform the market by 9.67%. During that period the price should oscillate between -25.50% and +59.76%.Get email alerts
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded in January 2008 and is headquartered in San Diego, CA.
At the moment the company generates 5M USD in revenues.
On its last earning announcement, the company reported a loss of -8.61$ per share.
The book value per share is 0.69$
Three months stock forecastNov. 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|